Translational research in smart delivery systems with liposomes for targeted best in class therapies
Platforms based on liposomes for selective and controlled delivery of drugs to the central nervous system.
Approaches focused on precision targeting of therapeutic agents.
Designed with manufacturing (GMP), stability, biodistribution, and cost-efficient scaling in mind.
Formulations, characterization, biodistribution studies in mouse models, and conditional release.
Key regulatory studies and IND/CTA submission package.
Patient trials to assess safety and early efficacy signals.
We are looking for clinical partners, CROs, and funding to accelerate development.